Strategic solutions to launch and manage your global products
Connect with our team and global biopharma professionals as we convene in Vienna at BIO-Europe 2025, the region’s gateway to the global life science community. Our support and operational excellence extend across key biotech and pharmaceutical areas:
- Market access strategy
- Regulatory affairs and CMC services
- Real-world evidence
- Patient safety and pharmacovigilance
Our experts at the conference
Marie-Charlotte von Brevern
Marie-Charlotte von Brevern is Senior Director, Global Program Management at Cencora PharmaLex, bringing over 25 years of expertise within the pharmaceutical and biotechnology sectors. Her extensive background spans R&D and clinical development through regulatory affairs and program management, supporting both major pharmaceutical companies and biotech enterprises. Currently, Marie-Charlotte assists international clients in identifying essential steps and required investments for successful market access, helping them develop strategic pathways for launch across their priority markets.
Eva Keck
Eva Keck is Vice President, Global Head of Commercial Operations at Cencora PharmaLex. With more than two decades in the pharmaceutical and biotechnology field, Eva brings comprehensive experience across multiple functions – from hands-on product management to overseeing numerous EU product launches during her tenure with major pharmaceutical and biotech companies. Eva now provides guidance to global clients seeking to penetrate key markets and achieve successful product launches and commercialization.
With team across North America, Europe, and Asia-Pacific region, we blend global reach with local expertise
3,000
Consultants worldwide
30+
Global markets covered
235+
Brands represented
Additional resources
Webinar
The Roadmap to Product Launch and Commercialization in Europe
Join our experts Marie-Charlotte von Brevern and Eva Keck in this available on-demand webinar. The European landscape offers significant opportunities and expansion potential for organizations looking to broaden their market presence and deliver breakthrough therapies to new patient populations. This webinar provides pharmaceutical and biopharmaceutical organizations with essential knowledge and tactical approaches to maximize opportunities within European markets.
Article
Roadmap to pharmaceutical commercialization in Europe
For pharmaceutical companies looking to diversify their market presence, spread financial risk, and build access to their portfolio, the European market has major potential. Not only does Europe have a large and diverse population, it also has robust national healthcare systems with governments investing significantly in healthcare infrastructure and services. Explore five critical things you need to know to enter the European market prepared to you by our experts Marie-Charlotte von Brevern and Eva Keck.
